Difference between revisions of "Zanotti S, et al. Endocr. Rev. (2016) cited as Ref 570 in DOI: 10.1038/s41392-020-0110-5 (Q9833)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Endocr. Rev., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Endocr. Rev. | ||
| Property / Published In Name String: Endocr. Rev. / rank | |||
| + | Normal rank | ||
Revision as of 21:05, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zanotti S, et al. Endocr. Rev. (2016) cited as Ref 570 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zanotti S
0 references
Canalis E
0 references
2016
0 references
Endocr. Rev.
0 references
